Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-09-16 | New | $11,400,001 | $11,400,001 | Equity Only | 06b | SEC link |
| 2023-06-21 | Amended | $10,121,691 | $2,110,026 | Equity Only | 06b | SEC link |
| 2023-04-28 | New | $8,011,665 | $8,011,665 | Equity Only | 06b | SEC link |
| 2021-12-23 | Amended | $30,262,815 | $27,262,815 | Equity and Debt | 06b | SEC link |
| 2021-03-31 | Amended | $9,000,000 | $1,214,350 | Equity Only | 06b | SEC link |
| 2021-01-05 | New | $3,000,000 | $3,000,000 | Equity and Debt | 06b | SEC link |
| 2020-04-07 | Amended | $7,785,650 | $1,410,104 | Equity Only | 06b | SEC link |
| 2020-02-25 | Amended | $6,375,546 | $4,375,546 | Equity Only | 06b | SEC link |
| 2019-05-03 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2018-04-03 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2017-11-21 | New | $625,000 | $625,000 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Joseph W Bagan | Director, Executive |
| Stephen Davis | Director |
| Abram Gordon | Director |
| Brad Hauert | Director |
| Scott Hawig | Director |
| Jeffrey L Hval | Director, Executive |
| Paul Jenny | Director |
| Chet Kaczor | Director |
| Carol Lewis | Director |
| Donna Lynne | Director |
| Jerrod Milton | Director |
| Dan Seff | Director |
| Mark M Spiecker | Director, Executive |
| Steven Summer | Director |